Press releases
-
ICON shareholders vote in favour of all resolutions at its Annual General Meeting
Dublin, Ireland, July 22, 2020
-
ICON reports second quarter 2020 results
Quarter 2 reported revenue of $620.2 million representing a year on year decrease of 10.8% or 10.3% on a constant currency basis.
-
-
-
ICON appoints new Chief Medical Officer
ICON announces the appointment of Dr Kristen Buck as the new Chief Medical Officer (CMO).
-
ICON reports first quarter 2020 results
Reported revenue of $715.1 million representing a 6.0% YoY increase or 6.5% on a constant currency basis. Net business wins of $867 million; a book to bill of 1.21.
-
ICON wins multiple categories in 2020 CRO Leadership Awards third year in a row
ICON recognised for specialised services offering across product development lifecycle, winning five awards overall.
-
ICON signs new service agreement with Pfizer
Agreement builds on the companies' existing relationship, under which ICON provides global expertise in the planning, execution, management and conduct of clinical trials.
-
ICON launches the Coronavirus Observatory
The Coronavirus Observatory applies powerful AI analysis and data visualisation to COVID-19 news and social media, providing updates on the latest vaccine trials.
-
ICON plc to present at Barclays Global Healthcare Conference 2020
The presentation will be webcast live from 10.15am EDT, Tuesday, March 10, 2020.
